参考文献/References:
[1] 郝洁,盛辉.骨质疏松症与血管相关性的研究综述[J].实用临床医药杂志,2016,,20(11)∶221-224.DOI∶10.7619/jcmp. 201611084.
[2] 王贺,阳琰,张国豪,等.2型糖尿病患者下肢血管病变与血清 25羟维生素D及骨密度的相关性[J].中国骨质疏松杂志,2017(11):6-9.DOI:10.3969/j issn.1006-7108.2017.11.001.
[3] De Pergola C,Triggiani V, Bartolomeo N, et al Independent relationship of osteocalcin circulating levels with obesity,type 2 diabetes, hypertension,and HDL cholesterol[J]. Endocr Metab Immumne Disord Drug Targets,2016,16(4):270-275.DOI:10. 2174/18715303176170106150756.
[4] Mokuda S, Sawada N, Matoba K, et al.Serum undercarboxylated osteocalcin level increases with 48 weeks of teriparatide treatment in pre-treated elderly rheumatoid arthritis patients who use antiresorptive drugs[J].J Endocrinol Invest,2012,35(9):796-799. DOI:10.1007/BF03347100.
[5] Richter B,Haller J,Haffner D,et al.Klotho modulates FGP23. mediated NO synthesis and oxidative stress in human coronary artery endothelial cells[J].Pflugers Arch,2016,468(9):1621-1635.DOI:10.1007/00424-016-1858-x.
[6] Zheng S,Zhang S,Song Y,et al.MicroRNA-297a regulates vascular calcification by targeting fibroblast growth factor 23[J].Iran J Basic Med Sci,2016,19(12):1331-1336.DOI:10.22038/ijbms.2016.7920.
[7] Zhou M,Ma X,Li H,et al.Serum osteocalin concentrations in relation to glucose and lipid metabolism in Chinese individuals [J].Eur J Endocrinol,2009,161(5):723-729.DOI:10.1530/EJE-09-0585.
[8] Guo Q,Li H,Xu L,et al.Undercarboxylated osteocalcin reverts insulin resistance induced by endoplasmic reticulum stress in human umbilical vein endothelial cells[J].Sci Rep,2017,7(1):46.DOI:10.1038/541598-017-00163-2.
[9]Krakauer JC,McKenna MJ,Buderer NF,et al.Bone loss and bone turnover in diabetes[J].Diabetes,1995,44(7):775-782.DOI: 0.2337/diab.44.7.775.
[10] 钟柏权,邱洁,巢秋霞,等.超声在2型糖尿病患者颈部及下肢动脉中检查对动脉斑块、闭塞程度诊断价值[J].中国医药科学,,2017(3)∶146-148.DOI∶10.3969/j.issn.20950616. 2017.03.042.
[11] Fukumoto S,Martin TJ.Bone as an endocrine organ[J].Trends Endocrinol Metab,2009,20(5):230-236.DOI:10.1016/j.tem. 2009.02.001.
[12] 段培林,张爱枝.慢性肾脏病患者血清成纤维细胞生长因子 23水平及其与冠状动脉钙化的关联研究[J].检验医学与临床,2018,15(21)∶3206-3208.DOI∶10.3969/j. issn.1672-9455.2018.21.013.
[13]He X,Hu X,Ma X,et al.Elevated serum fibroblast growth factor 23 levels an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus[J].Cardiovasc Diabetol,2017,16(1):77.DOI:10.1186/s12933-0170559-x.
[14] Dobnig H,Piswanger-S lkner JC,Roth M,et al. Type 2 diabetes mellitus in nursing home patients:effects on bone turnover, bone-mass,and fracture risk[J].J Clin Endocrinol Metab,2006,91 (9):355-363.DOI:10.1210/jc.2006-0460.
[15] Achemal L,Tellal S,Rkiouak F,et al. Bone metabolism in male patients with type 2 diabetes[J].Clin Rheumatol,2005,24(5):493-496.DOI:10.1007/10670-1070-9.
[16] Holvik K,van Schoor NM,Eekhoff EM,et al.Plasma osteocalcin levels as a predictor of cardiovascular disease in older men and women: a population-based cohort study[J].Eur J Endocrinol, 2014,71(2):161-170.DOI:10.1530/EJE-13-1044.
[17] Lee NK,Sowa H,Hinoi E,et al.Endocrine regulation of energy metabolism by the skeleton[J].Cell,2007,130(3):456-469. DOI:10.1016/j.call.2007.05.047.
[18]Ferron M,Hinoi E,Karsenty G,d d.Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice[J].Proc Natl Acad Sci U S A, 2008, 105( 13 ) : 5266-5270. DOI: 10. 1073/pnas. 0711119105.
[19]Hinoi E, Gao N,Jung DY,et al. The sympathetic tone mediates leptin’s inhibition of insulin secretion by modulating osteocalcin bioactivity[J].J Cell Biol , 2008,183(7) :1235-1242. DOI:10.1083/jcb. 200809113.
[20]Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism [ J].Cell ,2010,142(2) :296-308. DOI: 10. 1016/j. cell. 2010. 06.003.
[21]Mabilleau G, Pereira M , Chenu C. Novel skeletal effects of gluca-gon-like peptide-l ( GLP-1 ) receptor agonists[ J ]. J Endocrinol ,2018 ,236( 1) :R29-R42. DOI:10. 1530/JOE-17-0278.
[ 22]Wang H, Yoshiko Y, Yamamoto R , et al. Overexpression of fibro-blast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro[ J]. J Bone Miner Res , 2008 ,23(6) :939 -948. DOI:10.1359/jbmr. 080220.
相似文献/References:
[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍:2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(01):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(01):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(01):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(01):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(01):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(01):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(01):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]